Research map: Blinding Integrity and Psychedelic Drug Trials

Back to the article

Papers in this map

  1. Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression · Lea Julia Mertens · 2026 · 25 citations · Cited by this paper
  2. Optimizing Study Design for Clinically Useful Peripheral Molecular Biomarker Discovery in Psychiatry · 2026 · Related
  3. Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions · Zachary J. Williams · 2026 · 18 citations · Cited by this paper
  4. Error in Table · 2026 · Related
  5. Determining maximal achievable effect sizes of antidepressant therapies in placebo‐controlled trials · Fredrik Hieronymus · 2021 · 15 citations · Cited by this paper
  6. Medication and Procedural Abortion and Risk of Psychotropic Medication Use · 2026 · Related
  7. GH001 vs Placebo in Patients With Treatment-Resistant Depression · Wiesław Jerzy Cubała · 2026 · 12 citations · Cited by this paper
  8. Assessing Drug Efficacy After Multiple Negative Trials—Gepirone’s Journey Through the FDA · 2026 · Related
  9. Electroencephalography Microstates—A Biomarker for Psychosis? · 2026 · Related
  10. Deconstructing Social Functioning in Psychosis Risk—From Prediction to Recovery · 2026 · Related
  11. Confounding and Circularity in Actigraphy Prediction · 2026 · Related
  12. Psychedelics Trials and Outcomes—A Closer Look—Reply · 2026 · Related

Source: OpenAlex (CC0)